DaVita Inc. DVA is scheduled to report fourth-quarter 2024 results on Feb. 13, after the closing bell. See the Zacks Earnings ...

Piper Sandler reaffirmed its Neutral rating on Apellis Pharmaceuticals (NASDAQ:APLS) with a steady price target of $32.00. The firm's analysis was based on a recent survey of ophthalmologists ...

Micron CFO Mark Murphy mentioned various factors that could weigh on margins for next quarter, but he also said that period should mark the low point.

Despite big shake-ups to its Magnificent Seven colleagues, Meta’s shares have been on one of the best winning streaks in ...